Influenza A virus H7N9 vaccine (Medicago)

N/A

Report date: 2022/11/25 17:57:17

Base Information

Drug NameInfluenza A virus H7N9 vaccine (Medicago)
Drug Alias NamePlant-based H7N9 VLP vaccine - MedicagoPlant-made H7 virus-like particle influenza vaccine - MedicagoH7N9 VLP vaccine with GLA adjuvant - MedicagoH7 VLP influenza vaccine - MedicagoH7N9 vaccine - Medicago +[7] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Tract DiseasesRNA Virus InfectionsVirus Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedicago Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedicago Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract DiseasesRNA Virus InfectionsVirus Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia